The Newly Identified T Helper 22 Cells Lodge in Leukemia
-
Gholamreza Azizi
,
Mohsen Rastegar Pouyani
,
Shadi Sadat Navabi
,
Reza Yazdani
,
Fatemeh Kiaee
,
Abbas Mirshafiey
Abstract
Leukemia is a hematological tumor in which the malignant myeloid or lymphoid subsets play a pivotal role. Newly identified T helper cell 22 (Th22) is a subset of CD4(+) T cells with distinguished gene expression, function and specific properties apart from other known CD4(+) T cell subsets.Th22 cells are characterized by production of a distinct profile of effector cytokines, including interleukin (IL)-22, IL-13, and tumor necrosis factor-α (TNF-α). The levels of Th22 and cytokine IL-22 are increased and positively related to inflammatory and autoimmune disorders. Recently, several studies have reported the changes in frequency and function of Th22 in acute leukemic disorders as AML and ALL. This review discusses the role of Th22 and its cytokine IL-22 in the immunopathogenesis of leukemic disease.
CANCER STORY: CA Care 2014. Available from: http://cancercaremalaysia.com/category/leukemia.
Valbuena JR, Herling M, Admirand JH, et al. T-cell prolymphocytic leukemia involving extramedullary sites. American journal of clinical pathology. 2005; Mar; 123(3):456-64. PubMed PMID: 15716243.
Colvin GA, Elfenbein GJ. The latest treatment advances for acute myelogenous leukemia. Medicine and health, Rhode Island. 2003; Aug; 86(8):243-6. PubMed PMID: 14582219.
Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009; Jul 30; 114(5):937-51. PubMed PMID: 19357394.
Goldman D. Chronic lymphocytic leukemia and its impact on the immune system. Clinical journal of oncology nursing. 2000; Sep-Oct; 4(5): 233-4, 6. PubMed PMID: 11111455.
Camos M, Esteve J, Rimola A, et al. Increased incidence of acute myeloid leukemia after liver transplantation? Description of three new cases and review of the literature. Transplantation. 2004; Jan 27;77(2):311-3. PubMed PMID: 14743000.
Gale RP, Opelz G. Commentary: does immune suppression increase risk of developing acute myeloid leukemia? Leukemia. 2012 Mar; 26(3): 422-3. PubMed PMID: 21869837.
Pui CH, Schrappe M, Ribeiro RC, et al. Childhood and adolescent lymphoid and myeloid leukemia. Hematology / the Education Program of the American Society of Hematology American Society of Hematology Education Program. 2004; 118-45. PubMed PMID: 15561680.
Tian T, Yu S, Wang M, et al. Aberrant T helper 17 cells and related cytokines in bone marrow microenvironment of patients with acute myeloid leukemia. Clinical & developmental immunology. 2013; Pub Med PMID: 24023567. Pubmed Central PMCID: 3759248.
Varela N, Munoz-Pinedo C, Ruiz-Ruiz C, et al. Interferon-gamma sensitizes human myeloid leukemia cells to death receptor-mediated apoptosis by a pleiotropic mechanism. The Journal of biological chemistry. 2001; May 25; 276 (21): 17779-87. PubMed PMID: 11279136.
Zaki M, Douglas R, Patten N, et al. Disruption of the IFN-gamma cytokine network in chronic lymphocytic leukemia contributes to resistance of leukemic B cells to apoptosis. Leukemia research. 2000 Jul; 24(7): 611-21. PubMed PMID: 10867137.
Chae WJ, Gibson TF, Zelterman D, et al. Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis. Proceedings of the National Academy of Sciences of the United States of America.2010 Mar; 23.107(12): 5540-4. PubMed PMID: 20212110. Pubmed Central PMCID: 2851824.
Wang L, Yi T, Zhang W, et al. IL-17 enhances tumor development in carcinogen-induced skin cancer. Cancer research. 2010 Dec 15; 70(24): 10112-20. PubMed PMID: 21159633. Pubmed Central PMCID: 3059780.
Wu C, Wang S, Wang F, et al. Increased frequencies of T helper type 17 cells in the peripheral blood of patients with acute myeloid leukaemia. Clinical and experimental immunology. 2009 Nov; 158(2): 199-204. PubMed PMID: 19737137. Pubmed Central PMCID: 2768809.
Fan ZG, Zhang LS, Chai Y, et al. [The prevalence of Th17 cells in patients with acute myeloid leukemia.]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi; 2010 Sep; 31(9):617-20. PubMed PMID: 21122324.
Eyerich S, Eyerich K, Pennino D, et al. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. The Journal of clinical investigation. 2009 Dec; 119(12):3573-85. PubMed PMID: 19920355. Pubmed Central PMCID: 2786807.
Zhang N, Pan HF, Ye DQ. Th22 in inflammatory and autoimmune disease: prospects for therapeutic intervention. Molecular and cellular biochemistry. 2011 Jul; 353(1-2): 41-6. PubMed PMID: 21384158.
Tian T, Sun Y, Li M, et al. Increased Th22 cells as well as Th17 cells in patients with adult T-cell acute lymphoblastic leukemia. Clinica chimica acta; international journal of clinical chemistry. 2013 Nov; 15; 426: 108-13. PubMed PMID: 24064425.
Shao LL, Zhang L, Hou Y, et al. Th22 cells as well as Th17 cells expand differentially in patients with early-stage and late-stage myelodysplastic syndrome. PloS one. 2012; 7(12): e51339. PubMed PMID: 23236476. Pubmed Central PMCID: 3517399.
Cheng RH. Expression level of Th22 cells and its cytokines in patients with acute lymphoblastic leukemia and its significance. Journal of experimental hematology. 2013 Aug. 21(4): 857-60. PubMed PMID: 23998574. 21. Liu LM, Zhang XX, Zhang YM. [The change of peripheral blood Th22 cells in patients with acute myeloid leukemia]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 2012 Feb; 33(2):133-5. PubMed PMID: 22730667.
Kennedy MA. A brief review of the basics of immunology: the innate and adaptive response. The Veterinary clinics of North America Small animal practice. 2010 May; 40(3):369-79. PubMed PMID: 20471522.
Afzali B, Mitchell P, Lechler RI, John S, Lombardi G. Translational mini-review series on Th17 cells: induction of interleukin-17 production by regulatory T cells. Clinical and experimental immunology. 2010 Feb; 159(2):120-30. PubMed PMID: 19912251. Pubmed Central PMCID: 2810380.
Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. Journal of immunology. 1986 Apr 1; 136(7):2348-57. PubMed PMID: 2419430.
Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood. 2008 Sep 1; 112(5):1557-69. PubMed PMID: 18725574. Pubmed Central PMCID: 2518872.
Luckheeram RV, Zhou R, Verma AD, et al. CD4 (+)T cells: differentiation and functions. Clinical and developmental immunology. 2012; 925135. PubMed PMID: 22474485. Pubmed Central PMCID: 3312336.
Romagnani S. Biology of human TH1 and TH2 cells. Journal of clinical immunology. 1995 May; 15(3):121-9. PubMed PMID: 7559914.
Romagnani S. T-cell subsets (Th1 versus Th2). Annals of allergy, asthma & immunology: official publication of the American College of Allergy, Asthma, & Immunology. 2000 Jul; 85(1):9-18; quiz, 21. PubMed PMID: 10923599.
Feili-Hariri M, Falkner DH, Morel PA. Polarization of naive T cells into Th1 or Th2 by distinct cytokine-driven murine dendritic cell populations: implications for immunotherapy. Journal of leukocyte biology. 2005 Sep; 78(3): 656-64. PubMed PMID: 15961574.
Manetti R, Annunziato F, Tomasevic L, et al. Polyinosinic acid: polycytidylic acid promotes T helper type 1-specific immune responses by stimulating macrophage production of interferon-alpha and interleukin-12. European journal of immunology; 1995 Sep. 25(9):2656-60. PubMed PMID: 7589141.
Stelmaszczyk-Emmel A, Zawadzka-Krajewska A, Kopatys A, et al. Th1, Th2, Th17, and regulatory cytokines in children with different clinical forms of allergy. Advances in experimental medicine and biology. 2013; 788: 321-8. PubMed PMID: 23835993.
Amsen D, Blander JM, Lee GR, Tanigaki K, Honjo T, Flavell RA. Instruction of distinct CD4 T helper cell fates by different notch ligands on antigen-presenting cells. Cell. 2004 May 14; 117(4): 515-26. PubMed PMID: 15137944.
Owyang AM, Zaph C, Wilson EH, et al. Interleukin 25 regulates type 2 cytokine-dependent immunity and limits chronic inflammation in the gastrointestinal tract. The Journal of experimental medicine. 2006 Apr 17; 203(4): 843-9. PubMed PMID: 16606667. Pubmed Central PMCID: 1800834.
Szabo SJ, Kim ST, Costa GL, et al. A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell. 2000 Mar 17; 100(6):655-69. PubMed PMID: 10761931.
Wan YY, Flavell RA. TGF-beta and regulatory T cell in immunity and autoimmunity. Journal of clinical immunology. 2008 Nov; 28(6):647-59. PubMed PMID: 18792765. Pubmed Central PMCID: 2837280.
Chen Y, Kuchroo VK, Inobe J, et al. Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science. 1994 Aug 26;265(5176):1237-40. PubMed PMID: 7520605.
Fukaura H, Kent SC, Pietrusewicz MJ, et al. Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. The Journal of clinical investigation. 1996 Jul 1; 98 (1):70-7. PubMed PMID: 8690806. Pubmed Central PMCID: 507402.
Weiner HL. The mucosal milieu creates tolerogenic dendritic cells and T(R)1 and T(H)3 regulatory cells. Nature immunology. 2001 Aug; 2(8):671-2. PubMed PMID: 11477400.
Weiner HL. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunological reviews. 2001 Aug; 182: 207-14. PubMed PMID: 11722636.
Ramsdell F. Foxp3 and natural regulatory T cells: key to a cell lineage? Immunity. 2003 Aug; 19(2):165-8. PubMed PMID: 12932350.
Licona-Limon P, Henao-Mejia J, Temann AU, Gagliani N, Licona-Limon I, Ishigame H, et al. Th9 Cells Drive Host Immunity against Gastrointestinal Worm Infection. Immunity. 2013 Oct 17; 39(4):744-57. PubMed PMID: 24138883. Pubmed Central PMCID: 3881610.
Schlapbach C, Gehad A, Yang C, et al. Human TH9 Cells Are Skin-Tropic and Have Autocrine and Paracrine Proinflammatory Capacity. Science translational medicine. 2014 Jan 15; 6(219):219ra8. PubMed PMID: 24431112.
Ma CS, Tangye SG, Deenick EK. Human Th9 cells: inflammatory cytokines modulate IL-9 production through the induction of IL-21. Immunology and cell biology. 2010 Aug; 88(6):621-3. PubMed PMID: 20531361.
Dardalhon V, Awasthi A, Kwon H, et al. IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells. Nature immunology. 2008 Dec; 9(12): 1347-55. PubMed PMID: 18997793. Pubmed Central PMCID: 2999006.
Veldhoen M, Uyttenhove C, van Snick J, et al. Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nature immunology. 2008 Dec; 9(12):1341-6. PubMed PMID: 18931678.
Zhao P, Xiao X, Ghobrial RM, et al. IL-9 and Th9 cells: progress and challenges. International immunology. 2013 Oct; 25(10):547-51. PubMed PMID: 24027199. Pubmed Central PMCID: 3784066.
Dubin PJ, Kolls JK. Th17 cytokines and mucosal immunity. Immunological reviews. 2008 Dec; 226: 160-71. PubMed PMID: 19161423.
Azizi G, Jadidi-Niaragh F, Mirshafiey A. Th17 Cells in Immunopathogenesis and treatment of rheumatoid arthritis. International journal of rheumatic diseases. 2013 Jun; 16(3):243-53. PubMed PMID: 23981743.
Henriques A, Ines L, Couto M, P et al. Frequency and functional activity of Th17, Tc17 and other T-cell subsets in Systemic Lupus Erythematosus. Cellular immunology. 2010; 264(1):97-103. PubMed PMID: 20553755.
Sakai A, Sugawara Y, Kuroishi T, et al. Identification of IL-18 and Th17 cells in salivary glands of patients with Sjogren's syndrome, and amplification of IL-17-mediated secretion of inflammatory cytokines from salivary gland cells by IL-18. Journal of immunology. 2008 Aug 15; 181(4): 2898-906. PubMed PMID: 18684981.
Li J, Chen X, Liu Z, et al. Expression of Th17 cytokines in skin lesions of patients with psoriasis. Journal of Huazhong University of Science and Technology Medical sciences = Hua zhong ke ji da xue xue bao Yi xue Ying De wen ban = Huazhong keji daxue xuebao Yixue Yingdewen ban. 2007 Jun; 27(3):330-2. PubMed PMID: 17641855.
Shen H, Goodall JC, Hill Gaston JS. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis and rheumatism. 2009 Jun; 60 (6): 1647-56. PubMed PMID: 19479869.
Na SY, Park MJ, Park S, et al. Up-regulation of Th17 and related cytokines in Behcet's disease corresponding to disease activity. Clinical and experimental rheumatology. 2013 May-Jun; 31(3 Suppl 77): 32-40. PubMed PMID: 24064012.
Korn T, Bettelli E, Oukka M, et al. IL-17 and Th17 Cells. Annual review of immunology. 2009;27:485-517. PubMed PMID: 19132915.
Weaver CT, Hatton RD, Mangan PR, et al. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annual review of immunology. 2007; 25: 821-52. PubMed PMID: 17201677.
Ghilardi N, Ouyang W. Targeting the development and effector functions of TH17 cells. Seminars in immunology. 2007 Dec; 19(6): 383-93. PubMed PMID: 18083530.
Zhao X, Zhu D, Ye J, et al. The potential protective role of the combination of IL-22 and TNF-alpha against genital tract Chlamydia trachomatis infection. Cytokine. 2015 Feb 28; 73(1):66-73. PubMed PMID: 25734538.
Trifari S, Kaplan CD, Tran EH, et al. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nature immunology. 2009 Aug; 10(8): 864-71. PubMed PMID: 19578368.
Larsen M, Arnaud L, Hie M, et al. Multiparameter grouping delineates heterogeneous populations of human IL-17 and/or IL-22 T-cell producers that share antigen specificities with other T-cell subsets. European journal of immunology. 2011 Sep; 41(9): 2596-605. PubMed PMID: 21688259.
Truchetet ME, Brembilla NC, Montanari E, et al. Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease. Arthritis research & therapy. 2011; 13(5): R166. PubMed PMID: 21996293. Pubmed Central PMCID: 3308100.
Duhen T, Geiger R, Jarrossay D, et al. Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nature immunology. 2009 Aug; 10(8): 857-63. PubMed PMID: 19578369.
Baba N, Rubio M, Kenins L, et al. The aryl hydrocarbon receptor (AhR) ligand VAF347 selectively acts on monocytes and naive CD4 (+) Th cells to promote the development of IL-22-secreting Th cells. Human immunology. 2012 Aug; 73(8): 795-800. PubMed PMID: 22609446.
Alam MS, Maekawa Y, Kitamura A, et al. Notch signaling drives IL-22 secretion in CD4+ T cells by stimulating the aryl hydrocarbon receptor. Proceedings of the National Academy of Sciences of the United States of America. 2010 Mar 30; 107(13): 5943-8. PubMed PMID: 20231432. Pubmed Central PMCID: 2851859.
Ramirez JM, Brembilla NC, Sorg O, et al. Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells. European journal of immunology. 2010 Sep; 40(9): 2450-9. PubMed PMID: 20706985.
Fujita H, Nograles KE, Kikuchi T, et al. Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proceedings of the National Academy of Sciences of the United States of America. 2009 Dec 22; 106 (51): 21795-800. PubMed PMID: 19996179. Pubmed Central PMCID: 2799849.
Duluc D, Gannevat J, Anguiano E, et al. Functional diversity of human vaginal APC subsets in directing T-cell responses. Mucosal immunology. 2013 May; 6(3):626-38. PubMed PMID: 23131784. Pubmed Central PMCID: 3568194.
Acosta-Rodriguez EV, Rivino L, Geginat J, et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nature immunology. 2007 Jun; 8(6):639-46. PubMed PMID: 17486092.
Volpe E, Touzot M, Servant N, Marloie-Provost MA, Hupe P, Barillot E, et al. Multiparametric analysis of cytokine-driven human Th17 differentiation reveals a differential regulation of IL-17 and IL-22 production. Blood. 2009 Oct 22; 114(17):3610-4. PubMed PMID: 19704117.
Nograles KE, Zaba LC, Shemer A, et al. IL-22-producing "T22" T cells account for upregulated IL-22 in atopic dermatitis despite reduced IL-17-producing TH17 T cells. The Journal of allergy and clinical immunology. 2009 Jun; 123(6): 1244-52 e2. PubMed PMID: 19439349. Pubmed Central PMCID: 2874584.
Cella M, Fuchs A, Vermi W, et al. A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature. 2009 Feb 5; 457(7230): 722-5. PubMed PMID: 18978771. Pubmed Central PMCID: 3772687.
Mabuchi T, Takekoshi T, Hwang ST. Epidermal CCR6+ gammadelta T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis. Journal of immunology. 2011 Nov 15; 187(10): 5026-31. PubMed PMID: 21984702.
Takatori H, Kanno Y, Watford WT, et al. Lymphoid tissue inducer-like cells are an innate source of IL-17 and IL-22. The Journal of experimental medicine. 2009 Jan 16; 206(1): 35-41. PubMed PMID: 19114665. Pubmed Central PMCID: 2626689.
Wolk K, Kunz S, Witte E, et al. IL-22 increases the innate immunity of tissues. Immunity. 2004 Aug; 21(2): 241-54. PubMed PMID: 15308104.
Zenewicz LA, Flavell RA. Recent advances in IL-22 biology. International immunology. 2011 Mar; 23(3): 159-63. PubMed PMID: 21393631.
Lejeune D, Dumoutier L, Constantinescu S, et al. Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38 MAP kinase pathways in a rat hepatoma cell line. Pathways that is shared with and distinct from IL-10. The Journal of biological chemistry. 2002 Sep 13; 277(37): 33676-82. PubMed PMID: 12087100.
Rutz S, Eidenschenk C, Ouyang W. IL-22, not simply a Th17 cytokine. Immunological reviews. 2013 Mar; 252(1):116-32. PubMed PMID: 23405899.
Zhang L, Li YG, Li YH, et al. Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis. PloS one. 2012; 7(4): e31000. PubMed PMID: 22485125. Pubmed Central PMCID: 3317658.
Azizi G, Simhag A, El Rouby N, et al. Th22 Cells Contribution in Immunopathogenesis of Rheumatic Disease. Iranian Journal of Allergy, Asthma and Immunology. 2015; 14(3).
Benham H, Norris P, Goodall J, et al. Th17 and Th22 cells in psoriatic arthritis and psoriasis. Arthritis research and therapy. 2013; 15(5): R136. PubMed PMID: 24286492.
Xu W, Li R, Dai Y, et al. IL-22 secreting CD4+ T cells in the patients with neuromyelitis optica and multiple sclerosis. Journal of neuroimmunology. 2013 Aug 15; 261(1-2): 87-91. PubMed PMID: 23726764.
Li S, Jin T, Zhang HL, et al. Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barre syndrome and downregulated by IVIg treatments. Mediators of inflammation. 2014; 740947. PubMed PMID: 24899787. Pubmed Central PMCID: 4036596.
Liu LM, Zhang XX, Zhao GS, et al. [Change of Th22 cells in peripheral blood of patients with primary immune thrombocytopenia and clinical implication]. Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology. 2012 Dec; 28(12): 1314-6. PubMed PMID: 23232525.
Azizi G, Yazdani R, Hamid KM, et al. IL-22 Produced by T helper Cell 22 as a New player in the Pathogenesis of Immune Thrombocytopenia. Endocrine, metabolic & immune disorders drug targets. 2015 Mar 31; PubMed PMID: 25824530.
Huang Y, Xu T, Li J. Th22 cell is a gradually proved potential biomarker for acute coronary syndrome. Mediators of inflammation. 2014; 2014: 813926. PubMed PMID: 24895489. Pubmed Central PMCID: 4034660.
Liu LM, Zhang XX, Zhao GS, et al. [Change and significance of Th22 cells in patients with aplastic anemia]. Zhonghua yi xue za zhi. 2013 May 28; 93(20): 1537-40. PubMed PMID: 24028718.
Liu T, Peng L, Yu P, et al. Increased circulating Th22 and Th17 cells are associated with tumor progression and patient survival in human gastric cancer. Journal of clinical immunology. 2012 Dec; 32(6):1332-9. PubMed PMID: 22760549.
Zhuang Y, Peng LS, Zhao YL, et al. Increased intratumoral IL-22-producing CD4(+) T cells and Th22 cells correlate with gastric cancer progression and predict poor patient survival. Cancer immunology, immunotherapy: CII. 2012 Nov; 61(11): 1965-75. PubMed PMID: 22527243.
Lim C, Savan R. The role of the IL-22/IL-22R1 axis in cancer. Cytokine & growth factor reviews. 2014 Jun; 25(3):257-71. PubMed PMID: 24856143.
Savan R, McFarland AP, Reynolds DA, et al. A novel role for IL-22 R1 as a driver of inflammation. Blood. 2011 Jan 13; 117(2): 575-84. PubMed PMID: 20971950. Pubmed Central PMCID: 3031481.
Bard JD, Gelebart P, Anand M, et al. Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphoma. Leukemia. 2008 Aug; 22(8):1595-603. PubMed PMID: 18509351. Pubmed Central PMCID: 3429118.
Drexler HG, Gignac SM, von Wasielewski R, et al. Pathobiology of NPM-ALK and variant fusion genes in anaplastic large cell lymphoma and other lymphomas. Leukemia. 2000 Sep; 14(9): 1533-59. PubMed PMID: 10994999.
Zhang W, Chen Y, Wei H, et al. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts. Clinical cancer research: an official journal of the American Association for Cancer Research. 2008 Oct 15; 14(20): 6432-9. PubMed PMID: 18927282.
Zamo A, Chiarle R, Piva R, et al. Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death. Oncogene. 2002 Feb 7; 21(7):1038-47. PubMed PMID: 11850821.
Gangemi S, Allegra A, Alonci A, et al. Interleukin 22 is increased and correlated with CD38 expression in patients with B-chronic lymphocytic leukemia. Blood cells, molecules & diseases. 2013 Jan; 50(1): 39-40. PubMed PMID: 22909798.
Yu S, Liu C, Zhang L, et al. Elevated Th22 cells correlated with Th17 cells in peripheral blood of patients with acute myeloid leukemia. International journal of molecular sciences. 2014; 15(2): 1927-45. PubMed PMID: 24473142. Pubmed Central PMCID: 3958830.
Romerio F, Zella D. MEK and ERK inhibitors enhance the anti-proliferative effect of interferon-alpha2b. FASEB journal: official publication of the Federation of American Societies for Experimental Biology. 2002 Oct; 16(12): 1680-2. PubMed PMID: 12206994.
Fang JY, Richardson BC. The MAPK signalling pathways and colorectal cancer. The lancet oncology. 2005 May; 6(5): 322-7. PubMed PMID: 15863380.
Sun YX, Kong HL, Liu CF, et al. The imbalanced profile and clinical significance of T helper associated cytokines in bone marrow microenvironment of the patients with acute myeloid leukemia. Human immunology. 2014 Feb; 75(2): 113-8. PubMed PMID: 24269703.
Han Y, Ye A, Bi L, et al. Th17 cells and IL-17 increase with poor prognosis in patients with acute myeloid leukemia. Cancer science. 2014 May 29; PubMed PMID: 24890519.
Cui W, Sun J, Cotta CV, et al. Myelodysplastic syndrome with inv (3) (q21q26.2) or t (3; 3) (q21; q26.2) has a high risk for progression to acute myeloid leukemia. American journal of clinical pathology. 2011 Aug; 136 (2): 282-8. PubMed PMID: 21757602.
Zhu C, Ma Y, Xu XP. [Research progress on genes associated with transformation of myelodysplastic syndromes to acute myeloid leukemia]. Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology. 2014 May; 22(3): 873-8. PubMed PMID: 24989313.
Luczynski W, Stasiak-Barmuta A, Krawczuk-Rybak M, et al. Assessment of selected co-stimulatory, adhesion and activatory molecules and cytokines of Th(1)/Th(2) balance in acute lymphoblastic leukemia in children. Archivum immunologiae et therapiae experimentalis. 2005 Jul-Aug; 53(4): 357-63. PubMed PMID: 16088321.
Liu LM, Zhang XX, Zhao GS, et al. [The significance of change of Th22 cells in patients with acute lymphoblastic 2012 Dec; 33(12): 985-8.
| Files | ||
| Issue | Vol 9, No 3 (2015) | |
| Section | Articles | |
| Keywords | ||
| ALL AML IL-22 Leukemia Th22 | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
